HIV and AIDS-Sci Forschen

Full Text

Research Article
Study of Adenoid Hypertrophy in HIV Infected Individuals at a Tertiary Care Hospital

   Arpit Saxena*       Sonam Saxena   

Department of Otorhinolaryngology, UPRIMS & R, Saifai, Etawah, UP, India

*Corresponding author: Dr. Arpit Saxena, Department of Otorhinolaryngology, DTH, UPUMS, Saifai, Etawah, UP, India, 206130, Tel: +91-9532306179; E-mail: arpitsaxenaexam@gmail.com

Abstract

Aim: To study the status of adenoids in HIV infected individuals.

Introduction: Adenoid is the condensation of lymphoid tissue at the posterosuperior wall of nasopharynx. Adenoids are part of waldeyer’s ring. It is considered to have a crucial role in immunological memory of child. There are reported and documented evidences of adenoid hypertrophy in Human Immune Deficiency Syndrome (HIV) infected individuals but there lack a large study of such cases. The idea of present study is to observe the status of adenoids in HIV infected individuals.

Materials & Methods: The study was conducted in department of otolaryngology of a tertiary care hospital. Patients were selected randomly from the register of ART centre of hospital that was undergoing treatment. 100 patients were selected who gave consent to include in study. A thorough otolaryngology examination was carried out which also included anterior rhinoscopy. All patients were then subjected to diagnostic nasal endoscopy. Adenoid status was recorded and X- ray neck soft tissue lateral view was done to confirm adenoid hypertrophy.

Results: The mean age of patients was 37.6 years. Most of the patients (61%) were in age group of 31-45 years. Most of the patients (47%) have third degree of adenoid hypertrophy. 42% patients have insignificant (I and II degree) adenoid hypertrophy and 58% had significant (III and IV degree).

Conclusion: Adenoid hypertrophy is uncommon among adult individuals. It is significantly present in HIV infected adult individuals and should be ruled out as cause of nasal complaints.

Keywords

Human Immune Deficiency Virus (HIV); Acquired Immune Deficiency Syndrome (AIDS); Adenoid Hypertrophy (AH)

Introduction

Adenoid is the condensation of lymphoid tissue at the posterosuperior wall of nasopharynx. Adenoids form a part of waldeyer’s ring. It is considered to have a crucial role in immunological memory of child [1]. Adenoids are usually present in children and usually regress by 16 years [2].

Adenoids are usually not seen in adults and if seen are misdiagnosed and maltreated [3]. Adenoid hypertrophy (AH) in adults may be due to immunocompromised status such as organ transplant recipient, lymphoma and Acquired Immune Deficiency Syndrome (AIDS). Enlarged adenoids can achieve the size of a ping-pong ball and completely block the nasal passage. Further blockade may lead to recurrent sinusitis, rhinitis and acute otitis media.

There are reported and documented evidences of AH in Human Immune Deficiency Syndrome (HIV) infected individuals but there is lack of a large study of in such cases. The idea of present study is to observe the status of adenoids in HIV infected individuals. Present study was done on patients suffering with HIV and who are under antiretroviral therapy (ART).

Materials and Methods

The study was conducted in department of otolaryngology of a tertiary care hospital from October 2015 to March 2016. Patients were selected randomly from the register of ART centre of hospital that was undergoing treatment. Patients were communicated telephonically and were invited for study enrolment. 100 patients were selected who gave consent to include in study. The inclusion and exclusion criteria are as follows

Inclusion criteria

  1. Patients with regular follow up at ART centre
  2. Age>16 years of either sex
  3. Patient undergoing ART
  4. Willing for further investigations as advised

Exclusion criteria

  1. Patients having acute upper respiratory tract infection
  2. Pregnant and breast feeding patients
  3. Patients not giving consent

100 random patients were communicated by their registered telephone number in directory of ART centre. After obtaining inclusion and exclusion criteria patients were called in otolaryngology Outdoor Patient Department (OPD). Their detailed history of HIV infection duration and nasal complains if any were noted. A thorough otolaryngology examination was carried out which also included anterior rhinoscopy. All patients were then subjected to diagnostic nasal endoscopy.

Nasal endoscopy was performed after nasal decongestion with 4% lignocaine and 0.5% xylometazoline solution packs. Whole procedure was done with zero degree endoscope and Stammberger technique being used [4]. In order to decide the degree of adenoid hypertrophy, system used by Cassano et al. was used [5] (Table 1).

S.NO.

DEGREE

SPACE OCCUPIED BY ADENOIDS

1

I

Upper segment in the rhinopharyngeal cavity (<25%)

2

II

Upper half (<50%) of the rhinopharyngeal cavity

3

III

Extended over the rhinopharynx (<75%) with obstruction of choanal openings and partial closure of tube ostium

4

IV

Both the tube ostium and the lower choanal border could not be observed, (75-100%)

Table 1: Degree of Adenoid Hypertrophy

Patients having adenoid hypertrophy third degree and above were subjected to X- ray to confirm finding. X-ray nasopharynx lateral view in erect position with the neck extended and mouth opened was done to visualize the shadow of adenoid. All the results were documented and statically analyzed.

Results

The study was carried for 06 months in department of otolaryngology. 100 patients were included in study. The range of age varied from 17-56 years. The mean age of patients was 37.6 years. Most of the patients (61%) were in age group of 31-45 years. The age distribution is described in table 2.

S.NO.

AGE (YEARS)

NUMBER OF PATIENTS

1

17-30

11

2

31-45

61

3

>46

28

Table 2: Age Distribution

Out of 100 patients 39 were female and 61 were male. Sex distribution of patients is depicted in table 3. Duration of HIV infection is tabulated in table 4. Most of the HIV infected patients (61%) were known to be infected for 3-6 years. The duration of infection is accounted from the day patients were confirmed HIV positive by standard laboratory tests.

S.NO.

SEX

NUMBER OF PATIENTS

1

Male

61

2

Female

39

Table 3: Sex Distribution

S.NO

DURATION OF INFECTION (YEARS)

NUMBER OF PATIENTS

1

<3

14

2

3-6

61

3

6-9

25

Table 4: Duration of HIV Infection

Diagnostic nasal endoscopy was performed in each patient. 42% patients have insignificant (I and II degree) adenoid hypertrophy and 58% had significant (III and IV degree) AH. Results of adenoid hypertrophy are tabulated in table 5.

S.NO.

DEGREE OF ADENOID OBSTRUCTION

NUMBER OF PATIENTS

1

I

11

2

II

31

3

III

47

4

IV

11

Table 5: Adenoid Hypertrophy Distribution in Patients

Discussion

Santorini described nasopharyngeal aggregates or “Luschka tonsils” in year 1724 [6]. Wilhelm accounted for term nasopharyngeal vegetations as adenoid in 1870. The adenoid forms part in waldeyer’s ring that helps in preventing bacteria, virus and toxins entering the body. The adenoids are composed of B lymphocytes which form various antibodies against bacteria and viruses. Adenoids are usually hypertrophic in children and regresses by the age of 16 years.

Adenoids are like tonsils and can become hypertrophic in acute and chronic infections. Due to chronic infection and inflammation, adenoid gradually gets hypertrophic. Presence of AH in nasopharynx leads to nasal obstruction. Adenoids have shown to play crucial role in immunological memory of younger children. Although, adenoidectomy may sound immunologically undesirable [7] at young age but there has been no alteration in Immunoglobulin E level after adenoidectomy [8]. Adenoids physiologically get hypertrophy in children and regresses by 16 years [2].

However, adenoid usually regresses by 16 years of age but it is also seen in adult population [9,10]. Due to low incidence of adenoid enlargement in adults and access to adenoids is difficult by direct examination; many cases of adenoid hypertrophy are misdiagnosed and maltreated [3]. However, the adenoid hypertrophy causes are exactly unknown, but some reasons have been proposed. One of the causes is persistence of childhood adenoids associated with chronic inflammation [3]. Infection and irritant may also lead to proliferation of adenoids [11]. Finkestein et al. [12] shows that 30% heavy smokers had adenoid hypertrophy but in study of Barcin C et al. [13] smoking was not associated as a significant aetiology.

Hamdan et al. [14] documented prevalence of AH in patient with nasal obstruction to be 63.6% whereas Rout MR et al. [6] reported 21% prevalence. Barzan L et al. [15] found higher percentage of nasopharyngeal lymphatic tissue hypertrophy in HIV infected versus control group, both clinically and pathologically. Yousem DM et al. [16] study was done to measure the maximal dimension of nasophayngeal tissue with T 1 weighted magnetic resonance images and found that adenoids are more abundant in HIV infected person than control subjects. Erasmus T et al. [17] performed study in HIV infected individuals and found that most nasopharyngeal masses in HIV are due to lymphoid hyperplasia. In present study, the incidences of significant AH were 58% and form a significant number of subjects having AH.

The possible causes of adenoid hypertrophy in adults are allergic rhinitis, Non Hodgkin’s lymphoma, malignant tumours and AIDS [6]. Manifestation of AIDS in head and neck are among the most common complication of this disease. Some manifestation present as initial signs of HIV and others were present with full blown AIDS. AH can be one of the presentations [18].

In our study, we found a significant number of patients of AIDS to have adenoid hypertrophy irrespective of their nasal complaints. All the subjects were under antiretroviral therapy. In present study, most of the patients were of 31-45 years. The two possible reasons for this being that this group is more sexually active and it also corresponds to the national databases [19]. Most of individuals were male which also corresponded to national database [19]. 58% patients were having significant AH (third and fourth degree). Our study uncovers the presentation of significant AH in HIV infected individuals who were selected randomly. Further research should seek into histopathological examination and study of CD4 counts association with AH.

Conclusion

AH is uncommon among adult individuals. If found should be methodologically be investigated keeping AIDS as differential diagnosis. AH is significantly present in HIV infected adult individuals and should be ruled out as cause of nasal complaints.

References

  1. Wysocka J, Hassmann E, Lipska A, Musiatowicz M (2003) Naïve and memory T cells in hypertrophied adenoids in children according to age. Int J Pediatr Otorhinolaryngol 67: 237 241. [Ref.]
  2. Yildrim N, Sahan M, Karsliglu Y (2008) Adenoid hypertrophy in adults: clinical and morphological characteristics. J Int Med Res 36: 157-162.
  3. Kamel RH, Ishak EA (1990) Enlarged adenoid and adenoidectomy in adults: endoscopic approach and histopathological study. J Laryngol Otol 104: 965-967. [Ref.]
  4. Gleeson MJ, Clarke RC (2008) Scott-Brown’s Otorhinolaryngology Head and Neck surgery. Seventh edition, 2: 1347-1348. [Ref.]
  5. Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R (2003) Adenoid tissue rhinopharyngeal obstruction grading based on fiber endoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol 67: 1303-1309. [Ref.]
  6. Rout MR, Mohanty D, Vijaylaxmi Y, Bobba K, Metta C (2013) Adenoid Hypertrophy in Adults: A case Series. Ind J Otolaryngol Head Neck Surg 65: 269-274. [Ref.]
  7. Brandtezaeg P (2003) Immunology of the tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol 67 S69-S76. [Ref.]
  8. Modrzynski M, Zawisza E, Rapiejko P (2003) Serum immunoglobulin E levels in relation to Waldeyer’s ring surgery. Przegl Lek 60: 325-328. [Ref.]
  9. Yuce I, Somdas M, Ketenci I, Caqli S, Unlu Y (2007) Adenoidal vegetation in adults: an evaluation of 100 cases. Kulak Burun Boqaz Ihtis Derg 17: 130-132.
  10. Minnigerode B, Blass K (1974) Persistent adenoid hypertrophy [Die persistierende Rachenmandel-hypertrophy]. HNO 22: 347-349. [Ref.]
  11. Frenkiel S, Black MJ, Small P (1980) Persistent adenoid presenting as a nasopharyngeal mass. J Otolaryngol 9: 357-360. [Ref.]
  12. Finkelstein Y, Malik Z, Kopolovic J, Bernheim J, Djaldetti M, et al. (1997) Characterization of smoking-induced nasopharyngeal lymphoid hyperplasia. Laryngoscope 107: 1635-1642. [Ref.]
  13. Barcin C, Tapan S, Kursakloglu H (2005) Tu¨rkiye!desag¢likli genc¸ eris¸kinlerde koroner risk fakto¨rlerinin incelenmesi: Kesitsel bir analiz. Tu¨rk Kardiyoloji Dern Ars 33: 96-103.
  14. Hamdan AL, Sabra O, Hadi U (2008) Prevalence of adenoid hypertrophy in adult with nasal obstruction. J Otolaryngol Head Neck Surg 37: 469-473. [Ref.]
  15. Barzan L, Carbone A, Tirelli U, Crosalo M (1990) Nasopharyngeal lymphatic tissue in patients infected with HIV: A prospective Clinicopathologic study. Arch Otolaryngol Head Neck Surg 116: 928-931. [Ref.]
  16. Yousem DM, Loevner LA, Tobey JD, Geckle RJ, Bilker WB, et al. (1997) Adenoid width and HIV factors. Am J Neuroradiol 18: 1721-1725 [Ref.]
  17. Erasmus T, Daniller T, Goedhals J, Joubert G, Seedat RY (2013) The histology of nasopharyngeal masses: A comparison between HIV positive and negative patients. Eur Arch Otorhinolaryngol 270: 755-759. [Ref.]
  18. Moazzez AH, Alvi A (1998) Head and neck manifestations of AIDS in adults. Am Fam Physician 57: 1813-1822. [Ref.]
  19. National AIDS Control Organization (2015) India HIV Estimates. NACO Technical Report, Government of India, India. [Ref.]

Download Provisional PDF Here

 

Article Information

Article Type: Research Article

Citation: Saxena A, Saxena S (2016) Study of Adenoid Hypertrophy in HIV Infected Individuals at a Tertiary Care Hospital. J HIV AIDS 2(4): doi http://dx.doi.org/10.16966/2380-5536.133

Copyright: © 2016 Saxena A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication history: 

  • Received date: 01 Sep 2016

  • Accepted date: 25 Oct 2016

  • Published date: 31 Oct 2016
  •